NEW YORK (GenomeWeb) – A team led by researchers at the University of California, Berkeley and the University of California, San Francisco used CRISPR activation (CRISPRa) to identify enhancers of a gene that affects development of T cells, and thereby elucidate the occurrence of autoimmune disorders such as inflammatory bowel disease (IBD) and Crohn's disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.